Annual Accounts Payable
$21.51 M
-$4.10 M-16.02%
31 December 2023
Summary:
Cytokinetics Incorporated annual accounts payable is currently $21.51 million, with the most recent change of -$4.10 million (-16.02%) on 31 December 2023. During the last 3 years, it has risen by +$13.46 million (+167.17%). CYTK annual accounts payable is now -16.02% below its all-time high of $25.61 million, reached on 31 December 2022.CYTK Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$11.58 M
+$2.11 M+22.29%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly accounts payable is currently $11.58 million, with the most recent change of +$2.11 million (+22.29%) on 30 September 2024. Over the past year, it has dropped by -$2.21 million (-16.06%). CYTK quarterly accounts payable is now -54.78% below its all-time high of $25.61 million, reached on 31 December 2022.CYTK Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.0% | -16.1% |
| 3 y3 years | +167.2% | -28.6% |
| 5 y5 years | +471.4% | +239.4% |
CYTK Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.0% | +167.2% | -54.8% | +22.3% |
| 5 y | 5 years | -16.0% | +471.4% | -54.8% | +296.6% |
| alltime | all time | -16.0% | +1822.0% | -54.8% | +2017.2% |
Cytokinetics Incorporated Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.58 M(+22.3%) |
| June 2024 | - | $9.47 M(-27.0%) |
| Mar 2024 | - | $12.97 M(-39.7%) |
| Dec 2023 | $21.51 M(-16.0%) | $21.51 M(+55.9%) |
| Sept 2023 | - | $13.80 M(+9.8%) |
| June 2023 | - | $12.56 M(-27.6%) |
| Mar 2023 | - | $17.36 M(-32.2%) |
| Dec 2022 | $25.61 M(+21.5%) | $25.61 M(+77.5%) |
| Sept 2022 | - | $14.43 M(+2.5%) |
| June 2022 | - | $14.08 M(-29.0%) |
| Mar 2022 | - | $19.84 M(-5.9%) |
| Dec 2021 | $21.09 M(+162.0%) | $21.09 M(+30.0%) |
| Sept 2021 | - | $16.22 M(+8.7%) |
| June 2021 | - | $14.93 M(+92.2%) |
| Mar 2021 | - | $7.77 M(-3.5%) |
| Dec 2020 | $8.05 M(-1.3%) | $8.05 M(+19.5%) |
| Sept 2020 | - | $6.74 M(+130.8%) |
| June 2020 | - | $2.92 M(-17.2%) |
| Mar 2020 | - | $3.53 M(-56.8%) |
| Dec 2019 | $8.16 M(+116.8%) | $8.16 M(+139.2%) |
| Sept 2019 | - | $3.41 M(-34.3%) |
| June 2019 | - | $5.19 M(+103.9%) |
| Mar 2019 | - | $2.55 M(-32.3%) |
| Dec 2018 | $3.76 M(-28.3%) | $3.76 M(+86.0%) |
| Sept 2018 | - | $2.02 M(+51.5%) |
| June 2018 | - | $1.34 M(-44.9%) |
| Mar 2018 | - | $2.42 M(-53.9%) |
| Dec 2017 | $5.25 M(+24.0%) | $5.25 M(+28.8%) |
| Sept 2017 | - | $4.08 M(+128.8%) |
| June 2017 | - | $1.78 M(-41.4%) |
| Mar 2017 | - | $3.04 M(-28.2%) |
| Dec 2016 | $4.24 M(+89.3%) | $4.24 M(+534.1%) |
| Sept 2016 | - | $668.00 K(-76.5%) |
| June 2016 | - | $2.85 M(+420.3%) |
| Mar 2016 | - | $547.00 K(-75.6%) |
| Dec 2015 | $2.24 M(+64.4%) | $2.24 M(+17.4%) |
| Sept 2015 | - | $1.91 M(+19.1%) |
| June 2015 | - | $1.60 M(+15.0%) |
| Mar 2015 | - | $1.39 M(+2.3%) |
| Dec 2014 | $1.36 M | $1.36 M(-17.3%) |
| Sept 2014 | - | $1.65 M(+67.1%) |
| June 2014 | - | $985.00 K(-41.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $1.69 M(-54.5%) |
| Dec 2013 | $3.71 M(+72.4%) | $3.71 M(+107.3%) |
| Sept 2013 | - | $1.79 M(-0.7%) |
| June 2013 | - | $1.80 M(+65.8%) |
| Mar 2013 | - | $1.09 M(-49.5%) |
| Dec 2012 | $2.15 M(+78.1%) | $2.15 M(+41.8%) |
| Sept 2012 | - | $1.52 M(+45.1%) |
| June 2012 | - | $1.05 M(+13.0%) |
| Mar 2012 | - | $926.00 K(-23.3%) |
| Dec 2011 | $1.21 M(+8.0%) | $1.21 M(-16.7%) |
| Sept 2011 | - | $1.45 M(+44.3%) |
| June 2011 | - | $1.00 M(-3.8%) |
| Mar 2011 | - | $1.04 M(-6.6%) |
| Dec 2010 | $1.12 M(-33.5%) | $1.12 M(+10.5%) |
| Sept 2010 | - | $1.01 M(-15.3%) |
| June 2010 | - | $1.20 M(-29.6%) |
| Mar 2010 | - | $1.70 M(+1.0%) |
| Dec 2009 | $1.68 M(+21.8%) | $1.68 M(+24.8%) |
| Sept 2009 | - | $1.35 M(+46.0%) |
| June 2009 | - | $924.00 K(-26.4%) |
| Mar 2009 | - | $1.26 M(-9.1%) |
| Dec 2008 | $1.38 M(-12.8%) | $1.38 M(+36.4%) |
| Sept 2008 | - | $1.01 M(-38.9%) |
| June 2008 | - | $1.66 M(-28.1%) |
| Mar 2008 | - | $2.31 M(+45.6%) |
| Dec 2007 | $1.58 M(-44.2%) | $1.58 M(-36.8%) |
| Sept 2007 | - | $2.50 M(+12.8%) |
| June 2007 | - | $2.22 M(+22.4%) |
| Mar 2007 | - | $1.81 M(-36.0%) |
| Dec 2006 | $2.84 M(+20.7%) | $2.84 M(+15.9%) |
| Sept 2006 | - | $2.45 M(+29.5%) |
| June 2006 | - | $1.89 M(+16.9%) |
| Mar 2006 | - | $1.62 M(-31.3%) |
| Dec 2005 | $2.35 M(+14.2%) | $2.35 M(+72.2%) |
| Sept 2005 | - | $1.37 M(+76.7%) |
| June 2005 | - | $773.00 K(-38.3%) |
| Mar 2005 | - | $1.25 M(-39.2%) |
| Dec 2004 | $2.06 M(+29.6%) | $2.06 M(+69.6%) |
| Sept 2004 | - | $1.21 M(-37.0%) |
| June 2004 | - | $1.93 M(+86.6%) |
| Mar 2004 | - | $1.03 M(-35.1%) |
| Dec 2003 | $1.59 M(-1.2%) | $1.59 M |
| Dec 2002 | $1.61 M | - |
FAQ
- What is Cytokinetics Incorporated annual accounts payable?
- What is the all time high annual accounts payable for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual accounts payable year-on-year change?
- What is Cytokinetics Incorporated quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly accounts payable year-on-year change?
What is Cytokinetics Incorporated annual accounts payable?
The current annual accounts payable of CYTK is $21.51 M
What is the all time high annual accounts payable for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual accounts payable is $25.61 M
What is Cytokinetics Incorporated annual accounts payable year-on-year change?
Over the past year, CYTK annual accounts payable has changed by -$4.10 M (-16.02%)
What is Cytokinetics Incorporated quarterly accounts payable?
The current quarterly accounts payable of CYTK is $11.58 M
What is the all time high quarterly accounts payable for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly accounts payable is $25.61 M
What is Cytokinetics Incorporated quarterly accounts payable year-on-year change?
Over the past year, CYTK quarterly accounts payable has changed by -$2.21 M (-16.06%)